Leading Edge Medical Applications LLC is categorized under Health Services in Longview, TX and active since 2012.
Leading Edge Medical Applications LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Christopher L Dunnahoo at the company’s single location by writing to 4305 Windrush Boulevard, Longview, Texas TX 75604 or by phoning (903) 759-6338. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Leading Edge Medical Applications LLC |
Contact Person: | Christopher L Dunnahoo |
Address: | 4305 Windrush Boulevard, Longview, Texas 75604 |
Phone Number: | (903) 759-6338 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
Leading Edge Medical Applications LLC was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher L Dunnahoo for inquiries that concern Leading Edge Medical Applications LLC by calling the company number (903) 759-6338, as your correspondence is most welcome. Additionally, the physical location of the single location of Leading Edge Medical Applications LLC can be found at the coordinates 32.56031,-94.82444 as well as the street address 4305 Windrush Boulevard in Longview, Texas 75604.
For its online presence, you may visit Leading Edge Medical Applications LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.